NVS - Novartis to buy cancer drugmaker MorphoSys AG for EUR 2.7B February, 05 2024 05:02 PM Novartis AG 2024-02-05 17:02:22 ET Novartis ( NYSE: NVS ) said it will acquire cancer drugmake r MorphoSys AG ( MOR ) for EUR 68/share, or an aggregate of EUR 2.7B.... For further details see: Novartis to buy cancer drugmaker MorphoSys AG for EUR 2.7B